Other
Jan 2026Wound down in-person blood-draw services in Singapore while making the U.S. the primary home; company says Singapore dashboards and accounts remain accessible.
SourceBloodwork and personalized insights to help you live longer
Company research
Public company, workplace, funding, and market signals
Overview
YC S24 preventive-health company selling an at-cost lab-testing marketplace plus clinician-reviewed guidance, AI concierge support, and longitudinal biomarker tracking; expanded from Singapore to the U.S. and now serves customers across all 50 states.
Primary product
At-cost lab testing marketplace and preventive-health membership with Mito Concierge
Founded
2023
Headquarters
San Francisco, California, United States
Team size
10-20
Industry
Hospitals and Health Care
Sub-industry
Preventive health / longevity diagnostics
Offices
San Francisco, California, United States
Singapore
Business model
Membership subscription
At-cost / cost-plus marketplace
Pay-as-you-go lab ordering
Add-on consultations
Funding
Stage
Seed
Total raised
$4.1M
Latest round
Seed · Mar 2025
Latest amount
$2.2M
People & investors
Leadership
Co-Founder & CEO
Co-Founder & CTO
Chief Medical Officer
Care Team Lead
Founders
Co-Founder & CPO
Work & culture
Transparent, patient-first, and prevention-oriented; public messaging emphasizes no upsells, honest pricing, clinician-reviewed guidance, and evidence-based care.
Compensation
No official compensation bands were found. A third-party Beamstart listing showed a Head of Growth role at roughly $100k-$150k/year, but this is not confirmed by Mito Health.
Benefits
HSA/FSA eligible
Member pricing
Year-round clinician guidance
AI health chat / concierge
Longitudinal tracking
Personalized action plans
1:1 consults as add-ons
At-cost labs and scans
Early access to new diagnostics
Product & market
Pricing
$9/month membership plus pay-as-you-go published lab pricing; non-members can buy tests without a subscription, and consults are add-ons.
Differentiators
- —At-cost / cost-plus pricing instead of markup-driven test sales
- —1000+ marker/panel/scan/catalog breadth
- —Clinician-reviewed results with 1:1 consults
- —AI concierge and longitudinal tracking
- —Optional membership rather than a hard subscription lock-in
- —U.S.-wide lab access with Quest, Labcorp, and BioReference partners
Technology
Astro
Vercel
Cloudflare
Google Workspace
Let's Encrypt
PostHog
RudderStack
Amplitude
Stripe
Trustpilot
JSON-LD
Emotion
HTTP/3
Customers
U.S. consumers seeking preventive health and longevity care
People wanting biomarker-driven health tracking
Customers with concerns around energy, sleep, hormones, fertility, cardiovascular health, nutrients, inflammation, weight, and metabolic health
Competitors
Function Health
Superpower
InsideTracker
Lifeforce
Everlywell
Marek Health
Ezra
Prenuvo
Scale & contact
Estimated revenue
$1M-$10M
Estimated monthly visits
154.9K
Traffic estimate as of Jun 2026
Signals & risks
Latest news
Kenneth Lou on LinkedIn · Jul 2026
Launch of seven curated at-home kits covering heart, hormones, TRT, weight, and longevity; emphasizes transparent pricing and that not all tests can be done at home.
Mito Health · Jan 2026
Official announcement that the U.S. is now the primary home, Kenneth Lou relocated to San Francisco, and in-person Singapore blood-draw services were wound down.
Longevity.Technology · Mar 2025
Longevity-focused coverage of the seed round, the company’s biomarker-driven preventive-health product, and its use of AI plus clinician review.
Vulcan Post · Mar 2025
Coverage of the funding announcement, investor list, and the company’s U.S. expansion while winding down in-person blood draws in Singapore.
Mito Health · Mar 2025
Company announcement of a $2.2M seed round, bringing total funding to about $4M and naming new and existing investors; also notes U.S. expansion plans.
Jobs and careers at Mito Health
0 jobs at Mito Health
No open positions
Check back later for new openings